Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PLG/Plasminogen Protein, C-His

Catalog #:   EHB88101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: P00747
Protein length: Glu20-Arg580
Overview

Catalog No.

EHB88101

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Glu20-Arg580

Predicted molecular weight

66.02 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P00747

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Plasminogen, 3.4.21.7, Plasmin heavy chain A, Activation peptide, Angiostatin, Plasmin heavy chain A, short form, Plasmin light chain B, PLG

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human PLG/Plasminogen protein
References

Concomitant systemic thrombolytic therapy with tissue plasminogen activator for acute pulmonary embolism: a systematic review and meta-analysis., PMID:40514760

Elevated cerebrospinal fluid levels of SERPIN E1 in participants with lewy body diseases., PMID:40514404

Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role?, PMID:40513062

NFATC2/SERPINE1/JAK3/STAT3 signaling feedback loop in gastric cancer: immune evasion and anti-PD-1 resistance., PMID:40512406

Prediction of outcomes following intravenous thrombolysis in patients with acute ischemic stroke using serum UCH-L1, S100β, and NSE: a multicenter prospective cohort study employing machine learning methods., PMID:40511467

N-Glycosylation as a Key Requirement for the Positive Interaction of Integrin and uPAR in Glioblastoma., PMID:40508119

Deciphering the Complex Relationships Between the Hemostasis System and Infective Endocarditis., PMID:40507729

Prothrombotic fibrin clot phenotype as a risk factor for persistent left ventricular thrombus following acute myocardial infarction., PMID:40505869

Treatment outcomes in pediatric empyema: a retrospective observational study from a tertiary center in Dubai, United Arab Emirates., PMID:40504261

Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis., PMID:40503215

PAI1 regulating CHRNA1 contributes to primary focal hyperhidrosis: Clinical and experimental studies., PMID:40503176

Free Flap Salvage Using Extracorporeal Tissue Plasminogen Activator Administration: A Comparative Study., PMID:40502428

Thermodynamics and selection of the plasminogen activator inhibitor-1 latency transition., PMID:40501902

Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles., PMID:40498863

Transglutaminase 2-mediated glutamine deamidation enhances p21 stability during senescence., PMID:40498452

Plasminogen supplementation improves lysis of inflammatory retained traumatic hemothorax., PMID:40497789

Integrative multi-omics investigation of sleep apnea: gut microbiome metabolomics, proteomics and phenome-wide association study., PMID:40495162

Investigation of the Influence of Lipoprotein(a) and Oxidized Lipoprotein(a) on Plasminogen Activation and Fibrinolysis., PMID:40492181

Thrombolysis in dysfunctional valve and stroke., PMID:40491881

Safety and Feasibility of Endovascular Management of Pediatric Dialysis Access., PMID:40490623

Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress., PMID:40489346

Hip pain - an uncommon cause of extensive deep vein thrombosis (DVT) in the paediatric age group: a case report., PMID:40486006

Hemoglobin decline within 24 h post-mechanical thrombectomy as an indicator of poor clinical outcomes., PMID:40483900

Single-cell transcriptome sequencing reveals new epithelial-stromal associated mesenchymal-like subsets in recurrent gliomas., PMID:40483536

Corrigendum to "Babesia bigemina enolase binds to plasminogen and contains conserved B-cell epitopes that induce neutralizing antibodies in cattle" [Vet. Parasitol. 337 (2025), VETPAR 110503]., PMID:40450479

Diagnostic value of Novel Thrombus Markers in COPD with Deep Venous Thrombosis., PMID:40480301

Intravenous Glyburide in Medical and Endovascular-Treated Large-Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical Trial., PMID:40476628

Identification of a Novel Mutation in the SERPINE1 Gene Causing Clinical Hyperfibrinolysis in English Springer Spaniel Dogs., PMID:40470612

New horizons in the pharmacological management of venous thromboembolism., PMID:40469483

Therapeutic efficacy of budesonide suspension combined with poractant alfa injection for neonatal respiratory distress syndrome and its effect on serum ferritin and PAI-1 expressions., PMID:40469168

Effect of Prophylactic Intraoperative Tranexamic Acid on Postpartum Blood Loss Following Cesarean Section at a Single Center., PMID:40468921

Regulatory effects of lncRNA PVT1 on transcriptome in human breast cancer MDA-MB-231 cell line determined by in silico analyses., PMID:40464801

Distinct Inflammatory Imprint in Non-Cirrhotic and Cirrhotic Patients Before and After Direct-Acting Antiviral Therapy., PMID:40462644

Association between adiposity distribution and high-sensitivity C-reactive protein, adipokines, interleukins and plasminogen activator inhibitor-1., PMID:40461792

[Effects of total extract of Anthriscus sylvestris on immune inflammation and thrombosis in rats with pulmonary arterial hypertension based on TGF-β1/Smad3 signaling pathway]., PMID:40461203

Targeting Neutrophil Extracellular Traps: A New Strategy for the Treatment of Acute Ischemic Stroke Based on Thrombolysis Resistance., PMID:40461018

The Non-Nutritive Sweetner Erythritol Adversely Affects Brain Microvascular Endothelial Cell Function., PMID:40459966

Novel Urokinase-Type Plasminogen Activator Receptor-Targeting Optical Imaging Agent ICG-Glu-Glu-AE105 for Visualization of Malignant Glioma During Surgery: First-in-Human Study in 35 Patients with Brain Cancer., PMID:40459950

A review on anti-cancer properties of quercetin in gastric cancer., PMID:40458787

Molecular and clinical profiles of T2DM, dyslipidemia, and periodontitis: insights into inflammatory and metabolic dysregulation., PMID:40458179

Highly Adaptable Dendrimer Gel Nanoparticles with Dual Targeting of uPAR and Ribonucleotide Reductase R2 for Better Retention and Improved Therapeutic Outcomes in Triple-Negative Breast Cancer., PMID:40456699

Use of nebulised tranexamic acid in adult patients with cystic fibrosis: A retrospective audit., PMID:40456472

Functional Characterization of Plasminogen Activator Urokinase as a Key Gene in Papillary Thyroid Carcinoma Lymph Node Metastasis., PMID:40454923

Production of a Recombinant Fibrinolytic Protease from an Isolate of Serratia marcescens from the Amazon Basin., PMID:40454077

Tenecteplase in acute ischemic stroke: a new era in thrombolysis., PMID:40451189

Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectives., PMID:40450254

Modulatory effect of metformin and its transporters on immune infiltration in tumor microenvironment: a bioinformatic study with experimental validation., PMID:40450131

Vascular Assessment in Adult Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Study Report., PMID:40446733

Tumor Proteolytic Activity in Esophageal Cancer., PMID:40445536

Comparative efficacy of urokinase and recombinant tissue-type plasminogen activators in intraventricular hemorrhage., PMID:40445469

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PLG/Plasminogen Protein, C-His [EHB88101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only